Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-07-27
1993-01-12
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546175, A01N 4342, C07D21536, C07D21538
Patent
active
051791064
ABSTRACT:
Inhibiting leucotriene synthesis in patients with novel substituted N-(quinolin-2-yl-methoxy)benzylsulphonyl-urea of the formula ##STR1## in which A, B, D, E, G, K and M each independently is H, OH, halogen, CF.sub.3, OCF.sub.3, COOH, alkyl, alkoxy, alkoxycarbonyl or aryl,
REFERENCES:
patent: 4826987 (1989-05-01), Nielsen et al.
patent: 4876346 (1989-10-01), Musser et al.
patent: 4920132 (1990-04-01), Huang et al.
W. Forth, Allgemeine und Spezielle Pharmakologie und Toxikologie, 4th Edition, 1983.
JP 82 64 675, Application 80/140 091, Agricultural Chemistry, p. 6, Week E21, J5-C.
Fruchtmann Romanis
Kohlsdorfer Christian
Mohrs Klaus
Muller-Peddinghaus Reiner
Raddatz Siegfried
Bayer Aktiengesellschaft
Covington Raymond
Ivy C. Warren
LandOfFree
Substituted N-(quinolin-2-yl-methoxy) benzyl-sulphonylurea leuko does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted N-(quinolin-2-yl-methoxy) benzyl-sulphonylurea leuko, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted N-(quinolin-2-yl-methoxy) benzyl-sulphonylurea leuko will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1220456